Neoplasia

Article	Citations
Corrigendum to “Tumorigenicity of IL-1α- and IL-1β-Deficient Fibrosarcoma Cells” [Neoplasia, Volume 10, Issue 6, June 2008, Pages 549–562]	1683
DHX34 deficiency triggers tumor-intrinsic immunity via a dsRNA-mediated type I interferon pathway activation in HCC	115
Corrigendum to “Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells” [Neoplasia 17 (2014) 85]	100
The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells	59
ARID1A loss sensitizes colorectal cancer cells to floxuridine	59
Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma	55
5-Aza-2′-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD	53
High metastatic tumor-derived CXCL16 mediates liver colonization metastasis by inducing Kupffer cell polarization via the PI3K/AKT/FOXO3a pathway	53
L-methionine promotes CD8+ T cells killing hepatocellular carcinoma by inhibiting NR1I2/PCSK9 signaling	45
Visualizing mast cell migration to tumor sites using sodium iodide symporter of nuclear medicine reporter gene	45
Epitranscriptomic mechanisms of androgen signalling and prostate cancer	45
Single cell analysis unveils the commonality and heterogeneity between nasopharyngeal and oropharyngeal carcinoma	44
Sialylated IgG-activated integrin β4-Src-Erk axis stabilizes c-Myc in a p300 lysine acetyltransferase-dependent manner to promote colorectal cancer liver metastasis	42
Myxoid glioneuronal tumor: Histopathologic, neuroradiologic, and molecular features in a single center series	41
Combination of sunitinib and 177Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancer	40
Mutational signatures and their association with survival and gene expression in urological carcinomas	40
Time-restricted feeding affects the fecal microbiome metabolome and its diurnal oscillations in lung cancer mice	39
Combined radio-immunotherapy: An opportunity to increase the therapeutic ratio of oligometastasis-directed radiotherapy	39
Retraction notice to “Role of Autophagy as a Survival Mechanism for Hypoxic Cells in Tumors” [Neoplasia 18 (2016) 347- 355/201]	38
RUNX2 enhances bladder cancer progression by promoting glutamine metabolism	37
New horizons in B-cell lymphoma immunotherapy: From immune checkpoints to precision medicine	37
From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy	34
Tumor-Infiltrating Immune Cells in Colorectal Cancer	33
A spatiotemporal atlas of orchiectomy-induced androgen deprivation-mediated modulation of cellular composition and gene expression in the mouse prostate	31
Innate immunity: Looking beyond T-cells in radiation and immunotherapy combinations	31

The role of glycolysis in tumorigenesis: From biological aspects to therapeutic opportunities	30
Rezatapopt: A promising small-molecule “refolder” specific for TP53Y220C mutant tumors	29
Advanced progress of spatial metabolomics in head and neck cancer research	28
Identification of recurrent BRAF non-V600 mutations in intraductal carcinoma of the prostate in Chinese populations	28
Leptomeningeal dissemination in pediatric brain tumors	27
Lactate promoted cisplatin resistance in NSCLC by modulating the m6A modification-mediated FOXO3/MAGI1-IT1/miR-664b-3p/IL-6R axis	26
Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patients	26
Regulatory mechanisms of the Hippo/YAP axis by G-protein coupled estrogen receptor in gastric signet-ring cell carcinoma	25
Single-cell proteomic analysis reveals Multiple Myeloma heterogeneity and the dynamics of the tumor immune microenvironment in precursor and advanced states	25
Epigenetic DNA modifications and vitamin C in prostate cancer and benign prostatic hyperplasia: Exploring similarities, disparities, and pathogenic implications	25
STAT3 as a mediator of oncogenic cellular metabolism: Pathogenic and therapeutic implications	25
An open-label study to determine the maximum tolerated dose of oral ESK-440 administered as a single agent in patients with advanced or metastatic solid tumors	24
PDGF-BB overexpression in p53 null oligodendrocyte progenitors increases H3K27me3 and induces transcriptional changes which favor proliferation	23
Reciprocal regulation of lncRNA MEF and c-Myc drives colorectal cancer tumorigenesis	22
β-Catenin mediated TAM phenotype promotes pancreatic cancer metastasis via the OSM/STAT3/LOXL2 axis	22
Aurkin-A, a TPX2-Aurora A small molecule inhibitor disrupts Alisertib-induced polyploidy in aggressive diffuse large B cell lymphoma	22
A systematic review of microbiome-derived biomarkers for early colorectal cancer detection	21
A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR	20
Longitudinal genomic alternations and clonal dynamics analysis of primary malignant melanoma of the esophagus	20
Evidence based on Mendelian randomization: Causal relationship between mitochondrial biological function and lung cancer and its subtypes	20
Ovulation sources coagulation protease cascade and hepatocyte growth factor to support physiological growth and malignant transformation	20
Aurora kinase B is required for growth and expansion of medulloblastoma cells in the tissue context	19
Inhibiting HnRNP L-mediated alternative splicing of EIF4G1 counteracts immune checkpoint blockade resistance in Castration-resistant prostate Cancer	19
Incidence, mortality, and global burden of retinoblastoma in 204 countries worldwide from 1990 to 2021: Data and systematic analysis from the Global Burden of Disease Study 2021	19
Tumor-associated macrophages promote bladder cancer metastasis through the CCL20-CCR6 axis	19
Corrigendum to “SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT Pathway” [Neoplasia (2021) 23, 1037–1047]	19
HSP90 C-terminal domain inhibition promotes VDAC1 oligomerization via decreasing K274 mono-ubiquitination in Hepatocellular Carcinoma	18
SLC31A1 promotes chemoresistance through inducing CPT1A-mediated fatty acid oxidation in ER-positive breast cancer	18
Composition of gastrointestinal microbiota in association with treatment response in individuals with metastatic castrate resistant prostate cancer progressing on enzalutamide and initiating treatment	18
Pediatric neuro-oncology: Highlights of the last quarter-century	18
Overexpression of the miR-17-92 cluster in colorectal adenoma organoids causes a carcinoma-like gene expression signature	18
Sustained experimental activation of FGF8/ERK in the developing chicken spinal cord models early events in ERK-mediated tumorigenesis	17
High dose acetaminophen re-polarizes CD11b+ cells in the tumor microenvironment towards an activated macrophage phenotype	17
Amelioration of muscle wasting by gintonin in cancer cachexia	17
Medication adjustment of afatinib and combination therapy with sitagliptin for alleviating afatinib-induced diarrhea in rats	17
The DNA mismatch repair protein, MSH6 is a novel regulator of PD-L1 expression	16
Early separation and parallel clonal selection of dedifferentiated and well-differentiated components in dedifferentiated liposarcoma	16
Acral melanoma: new insights into the immune and genomic landscape	16
Indigenous peoples and inclusion in clinical and genomic research: Understanding the history and navigating contemporary engagement	16
MYH knockdown in pancreatic cancer cells creates an exploitable DNA repair vulnerability	16
Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1)	16
Comparative effects of combustible cigarette versus electronic cigarette exposures on KRAS mutant lung cancer promotion	16
Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma	15
Identification of TUBB3 as an immunotherapy target in lung cancer by genome wide in vivo CRISPR screening	15
Carcinogenesis induced by space radiation: A systematic review	15
Spatial profiling of METex14-altered NSCLC under tepotinib treatment: Shifting the immunosuppressive landscape	15
High-throughput sequencing and in-silico analysis confirm pathogenicity of novel MSH3 variants in African American colorectal cancer	15
PBI-05204, a supercritical CO2 extract of Nerium oleander, suppresses glioblastoma stem cells by inhibiting GRP78 and inducing programmed necroptotic cell death	15
Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeleton	15
Whole-chromosome arm acquired uniparental disomy in cancer development is a consequence of isochromosome formation	14

Targeting glycan sulfation in a CD11c+ myeloid population inhibits early KRAS-mutant lung neoplasia	14
Unveiling the impact of SUMOylation at K298 site of heat shock factor 1 on glioblastoma malignant progression	14
BRAF p.V600E mutation as a molecular boundary between genuine oligo-repeated and poly-metastatic disease in colorectal cancer	14
IGDQ motogenic peptide gradient induces directional cell migration through integrin (αv)β3 activation in MDA-MB-231 metastatic breast cancer cells	14
PAX8 modulates the tumor microenvironment of high grade serous ovarian cancer through changes in the secretome	14
Combining selinexor with alisertib to target the p53 pathway in neuroblastoma	14
Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5	14
A bioluminescence reporter mouse model for visualizing and quantifying CD8+ T cells in vivo	14
Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor	14
Why haven't we solved intracranial pediatric ependymoma? Current questions and barriers to treatment advances.	13
Corrigendum to “NFAT1 hypermethylation promotes epithelial‐mesenchymal transition and metastasis in nasopharyngeal carcinoma by activating ITGA6 transcription” [Neoplasia 21 (2019): 311–321]	13
Targeting myeloma metabolism: How abnormal metabolism contributes to multiple myeloma progression and resistance to proteasome inhibitors	13
Corrigendum to “Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma” [Neoplasia, Volume 21, Issue 3 (2019) 322–330]	13
Bacterial translocation and barrier dysfunction enhance colonic tumorigenesis	13
Impact of tissue penetration and albumin binding on design of T cell targeted bispecific agents	13
Genomics driven precision oncology in advanced biliary tract cancer improves survival	13
Spatial organization of heterogeneous immunotherapy target antigen expression in high-grade glioma	12
Current state of pediatric neuro-oncology imaging, challenges and future directions	12
Therapeutic effiacy of T cells expressing chimeric antigen receptor derived from a mesothelin-specific scFv in orthotopic human pancreatic cancer animal models	12
CYP1B1 promotes angiogenesis and sunitinib resistance in clear cell renal cell carcinoma via USP5-mediated HIF2α deubiquitination	12
Motion based ex vivo (MOTEX) culture of breast tumor slices sustains microenvironment composition	12
Metformin use and survival in people with ovarian cancer: A population-based cohort study from British Columbia, Canada	12
Corrigendum to “Tumor Therapy Mediated by Lentiviral Expression of shBcl-2 and S-TRAIL” [Neoplasia. Vol. 9, No. 5, May 2007, pp. 435–442]	12
FAPα and αSMA mark different subsets of fibroblasts in normal kidney and conventional renal cell carcinoma	12
Systemic inflammation in response to radiation drives the genesis of an immunosuppressed tumor microenvironment	12
Steatohepatitis alters lymphocytes cytotoxicity and localization, accelerating colorectal liver metastases	12
LncRNA HOTAIRM1 promotes radioresistance in nasopharyngeal carcinoma by modulating FTO acetylation-dependent alternative splicing of CD44	11
Phase I clinical trial of a novel procaspase-3 activator SM-1 with temozolomide in recurrent high-grade gliomas	11
Activation of PERK/eIF2α/ATF4 signaling inhibits ERα expression in breast cancer	11
DARPP-32 and t-DARPP in the development of resistance to anti-HER2 agents. Pre-clinical evidence from the STEP study	11
Proteomic profiling of canine fibrosarcoma and adjacent peritumoral tissue	11
Regulation of growth, invasion and metabolism of breast ductal carcinoma through CCL2/CCR2 signaling interactions with MET receptor tyrosine kinases	11
Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibition	11
Comprehensive profiling of EGFR mutation subtypes reveals genomic-clinical associations in non-small-cell lung cancer patients on first-generation EGFR inhibitors	11
CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation	11
Regulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells after treatment with dutasteride and lovastatin	11
Corrigendum to “DNA-methylation eraser TET2 activates WTIP expression to suppress an AKT-dependent chemoresistance of gastric cancer” [Neoplasia volume 2025 Apr 24:65:101166]	11
Synergizing radiotherapy and immunotherapy: Current challenges and strategies for optimization	11
Differential prognostic association of systemic inflammatory biomarkers on survival outcomes in head and neck squamous cell carcinoma patients by human papillomavirus status	11
Furin, ADAM, and γ-secretase: Core regulatory targets in the Notch pathway and the therapeutic potential for breast cancer	10
Multimodal profiling of oral squamous cell carcinoma identifies genomic alterations and expression programs associated with betel quid chewing	10
AEBP1 promotes papillary thyroid cancer progression by activating BMP4 signaling	10
ΔNp63 silencing, DNA methylation shifts, and epithelial-mesenchymal transition resulted from TAp63 genome editing in squamous cell carcinoma	10
Saturated fat exacerbates mitochondrial dysfunction through remodelling of ATP production and inflammation in Barrett’s oesophagus compared to monounsaturated fat, particularly in contrast to oesophag	10
The TRIM22-CDT2 axis is the key mediator of the p53-Rb signals in growth control of HPV-positive cervical carcinoma cells	10
The kinetics of blast clearance are associated with copy number alterations in childhood B-cell acute lymphoblastic leukemia	10
RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells	10
Targeting monopolar spindle kinase I (Mps1 or TTK) induces radiosensitization in syngeneic models of triple negative breast cancer (TNBC) and potentiates type I interferon (T1IFN) signaling	10
The renal clear cell carcinoma immune landscape	10
Activation of the CREB Coactivator CRTC2 by Aberrant Mitogen Signaling promotes oncogenic functions in HPV16 positive head and neck cancer	10
Contribution of the immune bone marrow microenvironment to tumor growth and bone deconstruction: implications for improving immunotherapeutic strategies in bone metastasis	9
Clinical and genetic drivers of oligo-metastatic disease in colon cancer	9
Corrigendum to “Single-cell proteomic analysis reveals Multiple Myeloma heterogeneity and the dynamics of the tumor immune microenvironment in precursor and advanced states” [Neoplasia 66 (2025) 11011	9
circUBR5 promotes ribosome biogenesis and induces docetaxel resistance in triple-negative breast cancer cell lines via the miR-340-5p/CMTM6/c-MYC axis	9
Common and distinct patterns of acquired uniparental disomy and homozygous deletions between lung squamous cell carcinomas and lung adenocarcinoma	9
SCFβ-TrCP targets Ajuba for degradation in a GSK3β-dependent manner in colorectal cancer	9
Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma	9
Deletion of the transcription factor ATF4 in a model of clear cell renal cell carcinoma	9
RRM2 inhibition alters cell cycle through ATM/Rb/E2F1 pathway in atypical teratoid rhabdoid tumor	9
Decoding androgen receptor signalling: Genomic vs. non-genomic roles in prostate cancer	9
Cholesterol and saturated fatty acids synergistically promote the malignant progression of prostate cancer	9
Generation of orthotopic intracranial glioblastoma patient-derived xenograft models: insights into extrachromosomal DNA-driven MYC(N) and PDGFRA oncogene amplification and preliminary therapeutic eval	9
Metformin combined with cisplatin reduces anticancer activity via ATM/CHK2-dependent upregulation of Rad51 pathway in ovarian cancer	9
Immunohistochemical and molecular evolutionary features of jejunoileal adenocarcinoma unveiled through comparative analysis with colorectal adenocarcinoma	9
Targeting interleukin 4 receptor alpha on tumor-associated macrophages reduces the pro-tumor macrophage phenotype	9
Non-melanoma skin cancers: physio-pathology and role of lipid delivery systems in new chemotherapeutic treatments	9
PRMT1 methylates METTL14 to modulate its oncogenic function	8
Histone H3 K27M-mediated regulation of cancer cell stemness and differentiation in diffuse midline glioma	8
Modulation of mitochondrial function by extracellular acidosis in tumor cells and normal fibroblasts: Role of signaling pathways	8
MYC alterations in multiple myeloma: Genetic insights and prognostic impact	8
Galectin-3 secreted by triple-negative breast cancer cells regulates T cell function	8
Maestros of malignancy: Microbes as the conductors of carcinogenesis	8
Hoxa11-mediated reduction of cell migration contributes to myeloid sarcoma formation induced by cooperation of MLL/AF10 with activating KRAS mutation in a mouse transplantation model	8
Selective BH3 mimetics synergize with BET inhibition to induce mitochondrial apoptosis in rhabdomyosarcoma cells	8
Non-canonical olfactory pathway activation induces cell fusion of cervical cancer cells	8
The antitumor activity of osimertinib plus palbociclib in non-small cell lung cancer patient-derived xenograft (PDX)/2D/3D culture models harboring EGFR amplification and CDKN2A/2B homozygous deletion	8
Cardiac substructures dosimetric predicts cardiac toxicity and prognosis in esophageal squamous cell cancer treated by radiotherapy	8
Tackling ALT-positive neuroblastoma: is it time to redefine risk classification systems? A systematic review with IPD meta-analysis	8
IL-6 facilitates cross-talk between epithelial cells and tumor- associated macrophages in Helicobacter pylori-linked gastric carcinogenesis	8
High-dose DFMO alters protein translation in neuroblastoma	8

Post-irradiation intratumoral heterogeneity modulates response to immune checkpoint inhibition therapy in a murine melanoma model	7
Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma –	7
Mitochondrial adaptation decreases drug sensitivity of persistent triple negative breast cancer cells surviving combinatory and sequential chemotherapy	7
Tumor-associated tissue eosinophilia promotes angiogenesis and metastasis in head and neck squamous cell carcinoma	7
RETRACTED: Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization	7
LGR6-dependent conditional inactivation of E-cadherin and p53 leads to invasive skin and mammary carcinomas in mice	7
Molecular heterogeneity in histomorphologic subtypes of lung adeno carcinoma represents a challenge for treatment decision	6
Hepatocellular loss of mTOR aggravates tumor burden in nonalcoholic steatohepatitis-related HCC	6
The breast tissue microbiome, stroma, immune cells and breast cancer	6
Diet-microbiome interactions in cancer treatment: Opportunities and challenges for precision nutrition in cancer	6
The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancer	6
Comparison of adjuvant gemcitabine plus S-1 with S-1 monotherapy for pancreatic ductal adenocarcinoma: Retrospective real-world data	6
Kv11.1-dependent senescence activates a lethal immune response via tumor necrosis factor alpha	6
Therapeutic avenues for targeting treatment challenges of diffuse midline gliomas	6
Myelodysplastic syndromes: Biological and therapeutic consequences of the evolving molecular aberrations landscape	6
Neuropilin-2 upregulation by stromal TGFβ1 induces lung disseminated tumor cells dormancy escape and promotes metastasis outgrowth	6
Past, present and future of Focused Ultrasound as an adjunct or complement to DIPG/DMG therapy: A consensus of the 2021 FUSF DIPG meeting	6
Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic cancer models for therapeutic testing	6
Panobinostat enhances olaparib efficacy by modifying expression of homologous recombination repair and immune transcripts in ovarian cancer	6
Overcoming ABCB1-mediated multidrug resistance by transcription factor BHLHE40	6
In vivo two-photon characterization of tumor-associated macrophages and microglia (TAM/M) and CX3CR1 during different steps of brain metastasis formation from lung cancer	6
The pan-cancer landscape of abnormal DNA methylation and intratumor microorganisms	6
Proteomic analysis uncovers biological diversity in molecularly defined endometrial carcinomas	6
Microbial molecules, metabolites, and malignancy	6
The promise of metabolic imaging in diffuse midline glioma	6
An effective multistage mouse model of esophageal carcinogenesis for preclinical and computational pathology applications	6
Mathematical modeling of radiotherapy and its impact on tumor interactions with the immune system	6
Prenatal p25-activated Cdk5 induces pituitary tumorigenesis through MCM2 phosphorylation-mediated cell proliferation	6
SOMCL-19-133, a novel, selective, and orally available inhibitor of NEDD8-activating enzyme (NAE) for cancer therapy	5
Exosomes in review: A new frontier in CAR-T cell therapies	5
Corrigendum to “Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E” [Neoplasia, volume 12,	5
Extracellular signals induce dynamic ER remodeling through αTAT1-dependent microtubule acetylation	5
Depletion of β1,6-N-acetylglucosaminyltransferase reduces E-selectin binding capacity and migratory potential of human gastrointestinal adenocarcinoma cells	5
Engineering and characterization of Hu3A4: A novel humanized antibody with potential as a therapeutic agent against myeloid lineage leukemias	5
Cell communication pathway prognostic model identified detrimental neurodevelopmental pathways in neuroblastoma	5
Comprehensive genomic profiling of Finnish lung adenocarcinoma cohort reveals high clinical actionability and SMARCA4 altered tumors with variable histology and poor prognosis	5
A synergistic approach for modulating the tumor microenvironment to enhance nano-immunotherapy in sarcomas	5
[18F]-FLT-PET to evaluate how the sequencing of chemotherapies impacts the efficacy of combination treatment in mouse models of triple-negative breast cancer	5
An antibody targeting an immune checkpoint molecule BTN2A2 enhances anti-tumor immunity	5
miRTARGET: An integrated web tool for the identification of microRNA targets with potential therapeutic or prognostic value in cancer	5
Granulocyte-macrophage colony-stimulating factor for newly diagnosed glioblastoma	5
Suppression of ER-stress induction of GRP78 as an anti-neoplastic mechanism of the cardiac glycoside Lanatoside C in pancreatic cancer	5
MLH1 mediates cytoprotective nucleophagy to resist 5-Fluorouracil-induced cell death in colorectal carcinoma	5
Comparison of differences in transcriptional and genetic profiles between intra-central nervous system and extra-central nervous system large B-cell lymphoma	5
Sequential treatment of anti-PD-L1 therapy prior to anti-VEGFR2 therapy contributes to more significant clinical benefits in non-small cell lung cancer	5
S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomas	5
Tumor neoantigens as key drivers of significant anti - tumor immunity in triple - negative breast cancer mouse models	5
Insights into the metastatic bone marrow niche gained from fibronectin and β1 integrin transgenic mice	5
DCZ0014, a novel compound in the therapy of diffuse large B-cell lymphoma via the B cell receptor signaling pathway	4
Pharmacological inhibition of the SKP2/p300 signaling axis restricts castration-resistant prostate cancer	4
Transcriptomic and proteomic profiling identifies feline fibrosarcoma as clinically amenable model for aggressive sarcoma subtypes	4
Secondary basophilic leukemia in Ph-negative myeloid neoplasms: A distinct subset with poor prognosis	4
Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells	4
Effect of MisMatch repair deficiency on metastasis occurrence in a syngeneic mouse model	4
GRP78 inhibitor YUM70 upregulates 4E-BP1 and suppresses c-MYC expression and viability of oncogenic c-MYC tumors	4
Proteome biology of primary colorectal carcinoma and corresponding liver metastases	4
Who benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-dimensional model for candidate selection	4
PI3K-CCL2-CCR2-MDSCs axis: A potential pathway for tumor Clostridia-promoted CD 8+ T lymphocyte infiltration in bile tract cancers	4
Corrigendum to Hypoxia induces docetaxel resistance in triple-negative breast cancer via the HIF-1 α/miR-494/Survivin signaling pathway [Volume 32 Number xxx Month 2022 pp. 100821]	4
A trio of tumor suppressor miRNA downregulates CREB5 dependent transcription to modulate neoadjuvant hormonal therapy sensitivity	4
FABP4 facilitates epithelial-mesenchymal transition via elevating CD36 expression in glioma cells	4
Construction of self-driving anti-αFR CAR-engineered NK cells based on IFN-γ and TNF-α synergistically induced high expression of CXCL10	4
Effects of PYCR1 on prognosis and immunotherapy plus tyrosine kinase inhibition responsiveness in metastatic renal cell carcinoma patients	4
Establishing a comprehensive panel of patient-derived xenograft models for high-grade endometrial carcinoma: molecular subtypes, genetic alterations, and therapeutic target profiling	4
Proteomic characterization of the pseudocapsule of clear cell renal cell carcinoma in VHL disease reveals a distinct microenvironment at the tumor boundary zone	4
Patient recruitment into clinical studies of solid malignancies during the COVID-19 pandemic in a tertiary cancer center	4
Retraction notice to Corrigendum to “Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization” [Neoplasia 31 (2022) 100805]	4
Corrigendum to “Hedgehog/GLI1 Transcriptionally Regulates FANCD2 in Ovarian Tumor Cells: Its Inhibition Induces HR-Deficiency and Synergistic Lethality with PARP Inhibition.” [Neoplasia Volume 23, Iss	4
Disruption of redox balance in glutaminolytic triple negative breast cancer by inhibition of glutaminase and glutamate export	4
Influence of alectinib and crizotinib on ionizing radiation - in vitro analysis of ALK/ROS1-wildtype lung tissue cells	4
YPEL2 regulates the efficacy of BRD4-EZH2 dual targeting in EZH2Y641mut germinal center-derived lymphoma	4
Characterization and integrated analysis of extrachromosomal DNA amplification in hematological malignancies	4
Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasis	4
Metabolic reprogramming by adenosine antagonism and implications in non-small cell lung cancer therapy	4
True cancer stem cells exhibit relative degrees of dormancy and genomic stability	4
Efficacy and safety of pyrotinib-based regimens in HER2 positive metastatic breast cancer: A retrospective real-world data study	4
Retraction notice to “Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization” [Neoplasia 27 (2022) 100784]	4
Towards a molecular understanding of the overlapping and distinct roles of UBQLN1 and UBQLN2 in lung cancer progression and metastasis	4
Specifying the choice of EGFR-TKI based on brain metastatic status for advanced NSCLC with EGFR p.L861Q mutation	4
Global molecular alterations involving recurrence or progression of pediatric brain tumors	4
NEDD9 is transcriptionally regulated by HDAC4 and promotes breast cancer metastasis and macrophage M2 polarization via the FAK/NF-κB signaling pathway	3
Corrigendum to “NF-κB p65 Overexpression Promotes Bladder Cancer Cell Migration via FBW7-Mediated Degradation of RhoGDIα Protein” [Neoplasia 19 (2017) 672–683]	3
Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastoma	3
A new, simplified endoscopic scoring system for predicting clinical outcome in gastric low-grade intraepithelial neoplasia: the “e-cout system”	3
Identification and characterization of circular RNAs as novel putative biomarkers to predict anti-PD-1 monotherapy response in metastatic melanoma patients – Knowledge from two independent internation	3
Hepatocellular carcinoma escapes immune surveillance through deceiving thymus into recalling peripheral activated CD8+ T cells	3
Altered endosomal-lysosomal biogenesis in melanoma	3
Characterization of circulating tumor cells in patients with metastatic bladder cancer utilizing functionalized microfluidics	3
RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer	3
Ovulation sources ROS to confer mutagenic activities on the TP53 gene in the fallopian tube epithelium	3
Retraction notice to Activation of hepatic stellate cells during liver carcinogenesis requires fibrinogen/integrin αvβ5 in zebrafish, NEO 20 (2018) 533-542.	3
Genomic landscape of metastatic lung adenocarcinomas from large-scale clinical sequencing	3
Druggable gene alterations in Japanese patients with rare malignancy	3
Clinical and genetic profile of Chinese patients with indolent natural killer-cell lymphoproliferative disorder of the gastrointestinal tract	3
Targeting IL-23 for the interception of obesity-associated colorectal cancer	3